Showing results (2231-2240 of 2,492) with videos related to
Sort By:
Pageof 250
Calcified Tissue International|April 12, 2019
Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Charlotte Beaudart, Yves Rolland, Alfonso J Cruz-Jentoft, et al.Journal of Affective Disorders|February 3, 2023
Measurement and assessment of grief in a large international sampleC Killikelly, A Kagialis, S Henneman, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE projectLorenz Balcar, Michael Schwarz, Livia Dorn, et al.Science (New York, N.Y.)|May 15, 2010
Erosion of lizard diversity by climate change and altered thermal nichesBarry Sinervo, Fausto Méndez-de-la-Cruz, Donald B Miles, et al.Cell Reports|August 24, 2025
A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapyAllison M Weis, Kaylyn M Bauer, William W Tang, et al.Journal for Immunotherapy of Cancer|March 17, 2023
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, et al.Community Mental Health Journal|January 25, 2023
Associations Between Primary Residence and Mental Health in Global Marginalized PopulationsD Knutson, M S Irgens, K C Flynn, et al.The American Journal of Sports Medicine|March 21, 2018
Immediate Removal From Activity After Sport-Related Concussion Is Associated With Shorter Clinical Recovery and Less Severe Symptoms in Collegiate Student-AthletesBreton M Asken, Russell M Bauer, Kevin M Guskiewicz, et al.Cancer Discovery|February 11, 2017
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)Alexander Drilon, Salvatore Siena, Sai-Hong Ignatius Ou, et al.Cancer Discovery|May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitorsGarrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.Pageof 250